An in vitro model for spontaneous angiogenesis using rat mesenteric endothelial cells: Possible therapeutic perspective for obesity and related disorders

Pharmaceutical Biology

Volumn 51, Issue 8, 2013, Pages 974-980

  Mansouri, Kamran ^a,b   Khodarahmi, Reza ^b,c   Ghadami, Seyyed Abolghasem ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Angiogenesis model; HUVEC; Macrovascular; Microvascular

Indexed keywords

ADIPOGENESIS; ANIMAL CELL; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROVASCULAR ENDOTHELIAL CELL; MOLECULAR PATHOLOGY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OBESITY; RAT; REVIEW;

ANIMALS; CELL MOVEMENT; CELL PROLIFERATION; COLLAGEN; ENDOTHELIAL CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MESENTERIC ARTERIES; MICROVESSELS; MODELS, BIOLOGICAL; MORPHOGENESIS; NEOVASCULARIZATION, PATHOLOGIC; OBESITY; RATS; SPECIES SPECIFICITY;

EID: 84885397140     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2013.773452     Document Type: Review

References (33)

1. Akahane T, Akahane M, Shah A, et al. (2004). Timp-1 inhibits microvascular endothelial cell migration by MMP-dependent and MMP-independent mechanisms. Exp Cell Res 301:158-67.
2. Auerbach R, Lewis R, Shinners B, et al. (2003). Angiogenesis assays: A critical overview. Clin Chem 49:32-40.
3. Bauer SM, Bauer RJ, Velazquez OC. (2005). Angiogenesis, vasculogenesis, and induction of healing in chronic wounds. Vasc Endovascular Surg 39:293-306.
4. Bayas A, Hummel V, Kallmann BA, et al. (2002). Human cerebral endothelial cells are a potential source for bioactive bdnf. Cytokine 19: 55-8.
5. Bouis D, Hospers GA, Meijer C, et al. (2001). Endothelium in vitro: A review of human vascular endothelial cell lines for blood vesselrelated research. Angiogenesis 4:91-102.
6. Brouillet S, Hoffmann P, Benharouga M, et al. (2010). Molecular characterization of eg-VEGF-mediated angiogenesis: Differential effects on microvascular and macrovascular endothelial cells. Mol Biol Cell 21:2832-43.
7. Cao Y. (2010). Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Nat Rev Drug Discov 9:107-15.
8. Chen J, Ran Y, Hong C, et al. (2010). Anti-cancer effects of celecoxib on nasopharyngeal carcinoma hne-1 cells expressing cox-2 oncoprotein. Cytotechnology 62:431-8.
9. Gagnon E, Cattaruzzi P, Griffith M, et al. (2002). Human vascular endothelial cells with extended life spans: In vitro cell response, protein expression, and angiogenesis. Angiogenesis 5:21-33.
10. Griffioen AW. (1997). Phenotype of the tumor vasculature; cell adhesion as a target for tumor therapy. Cancer J 10:249-55.
11. Hong Y, Kim MY, Yoon M. (2011). The anti-angiogenic herbal extracts ob-x from Morus alba, Melissa officinalis, and Artemisia capillaris suppresses adipogenesis in 3t3-l1 adipocytes. Pharm Biol 49:775-83.
12. Jackson CJ, Nguyen M. (1997). Human microvascular endothelial cells differ from macrovascular endothelial cells in their expression of matrix metalloproteinases. Int J Biochem Cell Biol 29:1167-77.
13. Jaffe EA, Nachman RL, Becker CG, Minick CR. (1973). Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52:2745-56.
14. Jain RK, Schlenger K, Hockel M, Yuan F. (1997). Quantitative angiogenesis assays: Progress and problems. Nat Med 3:1203-8.
15. Keshavarz M, Bidmeshkipour A, Mostafaie A, et al. (2011). Anti tumor activity of Salvia officinalis is due to its anti-angiogenic, antimigratory and anti-proliferative effects. Yakhteh 12:477-82.
16. Lang I, Pabst MA, Hiden U, et al. (2003). Heterogeneity of microvascular endothelial cells isolated from human term placenta and macrovascular umbilical vein endothelial cells. Eur J Cell Biol 82: 163-73.
17. Lijnen HR. (2008). Angiogenesis and obesity. Cardiovasc Res 78: 286-93.
18. Liu KH, Chan YL, Chan WB, et al. (2006). Mesenteric fat thickness is an independent determinant of metabolic syndrome and identifies subjects with increased carotid intimamedia thickness. Diabetes Care 29:379-84.
19. Madden SL, Cook BP, Nacht M, et al. (2004). Vascular gene expression in nonneoplastic and malignant brain. Am J Pathol 165:601-8.
20. Makrilia N, Lappa T, Xyla V, et al. (2009). The role of angiogenesis in solid tumours: An overview. Eur J Intern Med 20:663-71.
21. Michael J, Fowler MD. (2008). Microvascular and macrovascular complications of diabetes. Clin Diabetes 26:77-82.
22. Murakami S, Morioka T, Nakagawa Y, et al. (2001). Expression of adhesion molecules by cultured human glomerular endothelial cells in response to cytokines: Comparison to human umbilical vein and dermal microvascular endothelial cells. Microvasc Res 62:383-91.
23. Murray JC. (2001). Angiogenesis Protocols. Totowa (NJ): Humana Press.
24. Murthi P, So M, Gude NM, et al. (2007). Homeobox genes are differentially expressed in macrovascular human umbilical vein endothelial cells and microvascular placental endothelial cells. Placenta 28:219-23.
25. Relou IA, Damen CA, van der Schaft DW, et al. (1998). Effect of culture conditions on endothelial cell growth and responsiveness. Tissue Cell 30:525-30.
26. Ribatti D. (2009). Endogenous inhibitors of angiogenesis: A historical review. Leuk Res 33:638-44.
27. Snead MD, Papapetropoulos A, Carrier GO, Catravas JD. (1995). Isolation and culture of endothelial cells from the mesenteric vascular bed. Methods Cell Sci 17:257-62.
28. Sobrevia L, Abarzua F, Nien JK, et al. (2011). Review: Differential placental macrovascular and microvascular endothelial dysfunction in gestational diabetes. Placenta 32:S159-64.
29. Staton C, Lewis CE, Bicknell RJ. (2006). Angiogenesis Assays: A Critical Appraisal of Current Techniques. Chichester: J. Wiley & Sons.
30. Tseng FJ, Liu YK, Chung YS, et al. (2011). A fusion protein composed of receptor binding domain of vascular endothelial growth factor-a and constant region fragment of antibody: Angiogenesis antagonistic activity. Cytotechnology 63:285-93.
31. Vailhe B, Vittet D, Feige JJ. (2001). In vitro models of vasculogenesis and angiogenesis. Lab Invest 81:439-52.
32. Wang XH, Chen SF, Jin HM, Hu RM. (2009). Differential analyses of angiogenesis and expression of growth factors in micro- and macrovascular endothelial cells of type 2 diabetic rats. Life Sci 84: 240-9.
33. Yarani R, Mansouri K, Mohammadi-Motlagh HR, et al. (2013). In vitro inhibition of angiogenesis by hydroalcoholic extract of oak (Quercus infectoria) acorn shell via suppressing VEGF, MMP-2, and MMP-9 secretion. Pharm Biol 51:361-8.